Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Stocks to Watch: Groupon, Starbucks, Sirius

Stock quotes in this article: GRPN, SIRI, SBUX, GPN, CMCSA 

NEW YORK -- Groupon (GRPN) the online deals company revised its reported fourth-quarter results lower and said its independent auditor determined it has a "material weakness" in its internal controls.

Groupon affirmed its first-quarter guidance, reiterating its revenue forecast of between $510 million and $550 million.


Starbucks (SBUX) is planning a big expansion of its China business, according to reports.

The coffee-shop operator plans to triple its number of stores in China to 1,500 from 500 by 2015, said John Culver, the head of Starbuck's China and Asia Pacific business, according to The Wall Street Journal.

5 Chip Stocks J.P. Morgan Likes


Sirius XM Radio (SIRI) is appealing to federal regulators to prevent Liberty Media Corp. (LMCA) from taking over the satellite radio company.

Sirius revealed in a filing to the Federal Communications Commission on Friday that Liberty has asked the FCC for permission to take "de facto" control of Sirius.

But Sirius asked the FCC to "dismiss or deny" the application, the Journal said.

Liberty owns preferred stock that is convertible into about 40% of the outstanding common stock of Sirius.

5 Stocks Under $10 Poised to Move Higher


Credit card processor Global Payments (GPN) said Sunday night it "identified and self-reported unauthorized access into its processing system. "

Global Payments, in a press release, said hackers accessed its processing system and about 1.5 million card numbers "may have been exported. "The company said the breach was confined to North America. It said it believes the "incident is contained."


Comcast (CMCSA) reached a distribution deal with the Oprah Winfrey Network that will increase the number of homes that can view the network's programs, said a report.

Under the agreement, 17 million Comcast subscribers will have access to OWN, up from about 14 million right now, the Journal reported, citing people familiar with the situation.

Biotech Stock Mailbag: MAP Pharma, Affymax


-- Written by Joseph Woelfel



>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs